Candel Therapeutics (CADL) has an average rating of buy and mean price target of $21.75, according to analysts polled by FactSet.
What else is happening in Research?
Research
BofA Initiates Natural Grocers by Vitamin Cottage at Buy With $35 Price Target
BofA Initiates Natural Grocers by Vitamin Cottage at Buy With $35 Price Target
$NGVC
Research
JB Capital Markets Downgrades Banco Comercial Português to Neutral, Lifts PT
JB Capital Markets on Friday downgraded Portuguese lender Banco Comercial Português (BCP.LS) to neutral from buy and increased the price target to 1.30 euros from 1.18 euros.
$BCP.LS
Research
Barclays Upgrades Allegro.eu to Overweight Rating, Boosts PT
Barclays on Friday upgraded Polish e-commerce group Allegro.eu (ALE.WA) to overweight from equal weight and increased its price target to 61 Polish zlotys from 35 zlotys.
$ALE.WA